The aim is to determine the diagnostic efficacy , consequent therapeutic decision-making , and costs of OSA diagnosis using polysomnography ( PSG ) versus three consecutive studies of PM in patients with mild to moderate suspicion of sleep apnea or with comorbidity that can mask OSA symptoms .